Alterity Therapeutics (ATHE) Total Non-Current Liabilities (2009 - 2025)

Alterity Therapeutics' Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $42980.1 for Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 52.43% year-over-year to $42980.1 in Q4 2025; TTM through Dec 2025 was $42980.1, a 52.43% increase from a year earlier, with the FY2025 full-year figure at $56707.2, up 65.75% from the prior year.
• Total Non-Current Liabilities retreated to $42980.1 in Q4 2025 per ATHE's latest filing, from $56707.2 in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $56707.2 in Q2 2025 and bottomed at -$1.2 million in Q2 2024.
• The 5-year median for Total Non-Current Liabilities is $33909.0 (2022), against an average of -$82282.5.
• Across the five-year window, Total Non-Current Liabilities surged 388.34% in 2021 and plunged 93911.18% in 2024, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $28873.4 in 2021, then climbed by 7.74% to $31108.7 in 2022, then soared by 60.1% to $49804.0 in 2023, then tumbled by 43.38% to $28197.3 in 2024, then jumped by 52.43% to $42980.1 in 2025.
• Per Business Quant, the three latest ATHE Total Non-Current Liabilities figures stand at $42980.1 (Q4 2025), $56707.2 (Q2 2025), and $28197.3 (Q4 2024).